High on the list of breakthroughs expected to transform medicine is personalized medicine – the use of new methods of molecular analysis to better manage a patient’s disease or predisposition to disease. Personalized medicine is likely to change the way drugs are developed and medicine is prescribed. Yet many technological and financial systems that will support personalized medicine are not yet in place. The mission of the PMC is to build the foundation that underpins the advancement of personalized medicine as a viable solution to the challenges of efficacy, safety and cost.
The Science Policy committee evaluates the emerging applications of science and technology in personalized medicine, and serves as an advisory resource for other committees and for the PMC. It helps guide policies that govern work products and programs related to personalized medicine in an effort to advance personalized medicine in the public sphere. The committee also reviews material published on the PMC website and in the PMC's other publications for scientific and technical accuracy. The work of the committee will focus on: